These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30930441)

  • 1. A Simple and Easy Method of Monitoring Doxorubicin Release from a Liposomal Drug Formulation in the Serum Using Fluorescence Spectroscopy.
    Watanabe A; Murayama S; Karasawa K; Yamamoto E; Morikawa S; Takita R; Murata S; Kato M
    Chem Pharm Bull (Tokyo); 2019; 67(4):367-371. PubMed ID: 30930441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Analysis of DOXIL Stability and Drug Release from DOXIL by HPLC Using a Glycidyl Methacrylate-Coated Monolithic Column.
    Kimoto A; Watanabe A; Yamamoto E; Higashi T; Kato M
    Chem Pharm Bull (Tokyo); 2017; 65(10):945-949. PubMed ID: 28966279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiol-Triggered Release of Intraliposomal Content from Liposomes Made of Extremophile-Inspired Tetraether Lipids.
    Koyanagi T; Cifelli JL; Leriche G; Onofrei D; Holland GP; Yang J
    Bioconjug Chem; 2017 Aug; 28(8):2041-2045. PubMed ID: 28708392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer.
    Charrois GJ; Allen TM
    Biochim Biophys Acta; 2004 May; 1663(1-2):167-77. PubMed ID: 15157619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New liposomal doxorubicin nanoformulation for osteosarcoma: Drug release kinetic study based on thermo and pH sensitivity.
    Haghiralsadat F; Amoabediny G; Sheikhha MH; Zandieh-Doulabi B; Naderinezhad S; Helder MN; Forouzanfar T
    Chem Biol Drug Des; 2017 Sep; 90(3):368-379. PubMed ID: 28120466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leakage kinetics of the liposomal chemotherapeutic agent Doxil: The role of dissolution, protonation, and passive transport, and implications for mechanism of action.
    Russell LM; Hultz M; Searson PC
    J Control Release; 2018 Jan; 269():171-176. PubMed ID: 29122661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Flow-Through USP-4 Apparatus Drug Release Assay to Evaluate Doxorubicin Liposomes.
    Yuan W; Kuai R; Dai Z; Yuan Y; Zheng N; Jiang W; Noble C; Hayes M; Szoka FC; Schwendeman A
    AAPS J; 2017 Jan; 19(1):150-160. PubMed ID: 27485642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tracking Drugs and Lipids: Quantitative Mass Spectrometry Imaging of Liposomal Doxorubicin Delivery and Bilayer Fate in Three-Dimensional Tumor Models.
    Lopez A; Holbrook JH; Kemper GE; Lukowski JK; Andrews WT; Hummon AB
    Anal Chem; 2024 Jun; 96(22):9254-9261. PubMed ID: 38778440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal Co-Encapsulation of Two Novel Europium Complexes and Doxorubicin: Fluorescence Study.
    Trusova VM; Deligeorgiev T; Gorbenko G
    J Fluoresc; 2017 Jul; 27(4):1359-1363. PubMed ID: 28283899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New drug delivery nanosystem combining liposomal and dendrimeric technology (liposomal locked-in dendrimers) for cancer therapy.
    Gardikis K; Hatziantoniou S; Bucos M; Fessas D; Signorelli M; Felekis T; Zervou M; Screttas CG; Steele BR; Ionov M; Micha-Screttas M; Klajnert B; Bryszewska M; Demetzos C
    J Pharm Sci; 2010 Aug; 99(8):3561-71. PubMed ID: 20564386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrosprayed Myocet-like Liposomes: An Alternative to Traditional Liposome Production.
    Collier MA; Bachelder EM; Ainslie KM
    Pharm Res; 2017 Feb; 34(2):419-426. PubMed ID: 27896588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamer-based liposomes improve specific drug loading and release.
    Plourde K; Derbali RM; Desrosiers A; Dubath C; Vallée-Bélisle A; Leblond J
    J Control Release; 2017 Apr; 251():82-91. PubMed ID: 28238787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct biodistribution of doxorubicin and the altered dispositions mediated by different liposomal formulations.
    Luo R; Li Y; He M; Zhang H; Yuan H; Johnson M; Palmisano M; Zhou S; Sun D
    Int J Pharm; 2017 Mar; 519(1-2):1-10. PubMed ID: 28063903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
    Haghiralsadat F; Amoabediny G; Helder MN; Naderinezhad S; Sheikhha MH; Forouzanfar T; Zandieh-Doulabi B
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):169-177. PubMed ID: 28376641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photocontrollable Intermittent Release of Doxorubicin Hydrochloride from Liposomes Embedded by Azobenzene-Contained Glycolipid.
    Liu D; Wang S; Xu S; Liu H
    Langmuir; 2017 Jan; 33(4):1004-1012. PubMed ID: 27668306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of liposomal doxorubicin exhibiting ultrasensitivity against phospholipase A
    Tagami T; Ando Y; Ozeki T
    Int J Pharm; 2017 Jan; 517(1-2):35-41. PubMed ID: 27865984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
    Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
    J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate receptor-targeted liposomal nanocomplex for effective synergistic photothermal-chemotherapy of breast cancer in vivo.
    Nguyen VD; Min HK; Kim CS; Han J; Park JO; Choi E
    Colloids Surf B Biointerfaces; 2019 Jan; 173():539-548. PubMed ID: 30343218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
    Moosavian SA; Abnous K; Badiee A; Jaafari MR
    Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.